Hidden Sugar Switch: How Plant Steroid Hormones Seize Direct Control of Metabolism
Every seed is a wager on sugar. Inside an oilseed such as rapeseed or castor bean lies a cache of fat that must be converted, molecule by molecule, into the sucrose that powers a seedling’s first days of life. How a young plant schedules that conversion—and how it decides to accelerate it—has long been one of the murkier corners of plant metabolism. A study published in Nature Plants now illuminates a strikingly direct control mechanism. Zhang and colleagues report that brassinosteroids, the plant steroid hormones long prized for coaxing crops into growing bigger and standing taller, promote sugar synthesis by protecting a central metabolic enzyme from being switched off through phosphorylation by a signaling kinase called BIN2. In one stroke, the work fuses two research worlds that have largely run on parallel tracks: the hormonal regulation of plant growth and the nitty-gritty biochemistry of how carbon is funneled into sugar. It does so with an added twist of evolutionary irony, because the logic it uncovers looks uncannily like the way insulin manages sugar in our own bodies.
Brassinosteroids entered science through a botanical curiosity. In the late 1970s, chemists teased a few milligrams of a growth-promoting substance out of kilograms of rapeseed pollen and christened it brassinolide. Its structure came as a surprise: a polyhydroxylated steroid, strikingly similar in architecture to the hormones that run animal physiology, yet operating in organisms with no cholesterol-based endocrinology of their own. Over the following decades the hormones proved indispensable. Plants that cannot synthesize or sense them grow into extreme dwarfs with curled, dark-green leaves, sterile flowers and malformed vasculature, while plants awash in them elongate vigorously, divide cells faster, tolerate drought, cold and salinity, and time their senescence differently. Agriculturalists took notice early, and field trials have repeatedly hinted that brassinosteroid treatments can nudge yields upward, particularly under stress. Yet for all the accumulated lore, these hormones have been understood primarily as growth signals—molecules that tell genes when to build cell walls, when to elongate, when to specialize. The new study argues that their portfolio is far broader than that: they are also metabolic managers, with their fingers directly on the levers of sugar production.
To appreciate what the researchers found, it helps to recall how brassinosteroid signaling has conventionally been drawn. The hormone is detected at the cell surface by BRI1, a leucine-rich repeat receptor kinase that teams up with a co-receptor called BAK1. In the hormone’s absence, a kinase named BIN2—brassinosteroid-insensitive 2, a member of the glycogen synthase kinase 3, or GSK3, family—runs unchecked. BIN2 phosphorylates two transcription factors, BZR1 and BES1, that sit at the heart of the pathway; phosphorylation drives them out of the nucleus and tags them for destruction by the proteasome, keeping the brassinosteroid program silenced. When the hormone arrives, the activated receptor complex sets off events that restrain BIN2, allowing protein phosphatases to strip phosphates from BZR1 and BES1, which then accumulate and retune thousands of genes governing cell expansion, development and stress responses. This cascade, pieced together over roughly a quarter century, mostly in the reference plant Arabidopsis, has usually been depicted as a straight line from membrane to nucleus: a hormone dialing gene expression up and down. The new work reveals that the line takes an unscheduled detour through the cytoplasm, stopping at an enzyme of core carbon metabolism.
The enzyme in question is phosphoenolpyruvate carboxykinase, or PEPCK, one of the most consequential catalysts in biology. It converts oxaloacetate into phosphoenolpyruvate, consuming a molecule of ATP and releasing carbon dioxide along the way. That single reaction is the committed, often rate-controlling step of gluconeogenesis—the construction of glucose and, in plants, sucrose from carbon that does not begin as sugar. In animals, liver PEPCK is the gateway through which amino acids and lactate re-enter the carbohydrate economy during fasting, and its hormonal regulation is textbook material. In plants, PEPCK takes the starring role during germination. Oilseed embryos mobilize stored triglycerides into acetyl-CoA, run the glyoxylate cycle to convert that acetyl-CoA into organic acids, and then depend on PEPCK to hoist those acids into phosphoenolpyruvate, the springboard from which sucrose is assembled and shipped to the growing root and shoot. Until a seedling unfurls its first green leaf and photosynthesis takes over, this lipid-to-sugar pipeline is quite literally its life support. PEPCK also decarboxylates organic acids in certain C4 and CAM photosynthetic plants and has been implicated in cellular pH regulation, giving it a résumé that spans both development and daily carbon economics.
What Zhang and colleagues now demonstrate is that BIN2 phosphorylates PEPCK directly, and that this phosphorylation acts as a brake on the enzyme’s contribution to sugar synthesis. When brassinosteroid levels rise, the signaling cascade reins BIN2 in; PEPCK escapes phosphorylation and remains in its productive, unmodified state, and carbon flows onward into sugar. When brassinosteroid signaling is weak, BIN2 phosphorylates the enzyme and sugar production is dialed down. The finding matters because of what it adds to BIN2’s client list. For some twenty-five years, the kinase’s known substrates have been overwhelmingly transcriptional—BZR1, BES1 and their relatives—so the pathway’s output seemed synonymous with changes in gene expression. A metabolic enzyme sitting directly under the kinase’s thumb means brassinosteroids can also regulate metabolism post-translationally, adjusting the behavior of proteins already on duty within minutes, without waiting for new messenger RNA to be transcribed or translated. Hormone and metabolism are no longer connected only through the slow, indirect route of transcriptional reprogramming; they are wired together by a single, fast, reversible chemical mark stamped onto one enzyme.
The deepest resonance of the discovery is comparative. In mammals, insulin is the archetypal metabolic hormone: it engages a receptor kinase, launches a phosphorylation cascade that activates the enzyme Akt, and Akt shuts down GSK3 by adding an inhibitory phosphate to it. With GSK3 silenced, glycogen synthase escapes its own inhibitory phosphorylation, and muscle and liver move to bank glucose as glycogen. The plant pathway now uncovered rhymes almost bar for bar: a steroid hormone engages a membrane receptor kinase, the ensuing signaling cascade restrains a GSK3-family kinase—BIN2—and a metabolic enzyme, PEPCK, escapes phosphorylation and pushes carbon into sugar. Plants and animals parted evolutionary ways well over a billion years ago, and although brassinosteroids are chemically reminiscent of animal steroids, they are perceived by receptor machinery that shares no common ancestry with our own. Yet both lineages appear to have converged on the same control logic: a metabolic enzyme held in check by a GSK3-family kinase, liberated when a hormonal signal silences that kinase. Whether this reflects deep homology or genuine convergent evolution is a question the study cannot settle, but either answer is captivating—and either says something profound about how readily biology rediscovers this particular design.
For agriculture, the implications are concrete. A seedling’s fate often hinges on how efficiently it converts its seed reserves into usable sugar before photosynthesis takes over; sluggish conversion means weak establishment, and weak establishment means patchy stands and lost yield in oilseed crops from canola to soybean. Brassinosteroids are already on breeders’ radar because genes that shape hormone levels and sensitivity influence dwarfing, lodging resistance and grain yield in cereals. The new work supplies a molecular rationale for why a growth hormone should be so tightly entangled with productivity: growth and fuel are two sides of one ledger, and a plant can only elongate as fast as its sugar supply allows. A hormone that unleashes expansion must also arrange the budget to pay for it, and the BIN2–PEPCK connection is precisely such an arrangement made explicit. If the phosphorylation sites that BIN2 targets on PEPCK can be pinpointed, genome editing might one day install versions of the enzyme that shrug off the brake, potentially strengthening seedling vigor or redirecting carbon flux in ways that enlarge harvestable biomass. The pathway also offers an appealing node for selection: varieties that keep sugar synthesis running when stress would otherwise throttle it could prove more resilient in a volatile climate.
Plenty of detail remains to be filled in. A demonstration this elegant inevitably raises the questions that follow any new wiring diagram: in which tissues and developmental windows does the BIN2–PEPCK interaction dominate—germinating seeds, developing fruits, photosynthesizing leaves? How, at the structural level, does phosphorylation alter the enzyme’s kinetics, its stability or its localization inside the cell? And how does this fast post-translational layer of control mesh with the slower transcriptional arm of the pathway, given that BZR1 and BES1 are known to regulate metabolic genes as well? Conservation is another open question: PEPCK wears different hats in different species, including its photosynthetic role in PEPCK-type C4 crops such as certain tropical grasses, so the hormone–metabolism link will need to be mapped across the plant kingdom before its agricultural promise can be properly assessed. None of these uncertainties dents the central conceptual shift. Brassinosteroid signaling, long narrated as a story about transcription factors, is also a story about enzymes: the hormone’s reach extends beyond the nucleus, into the reaction vessels of the cytoplasm where carbon is actually rearranged into sugar.
It is a fitting development for hormones that were discovered in pollen and suspected, at first, of being little more than curiosities. Half a century on, the brassinosteroids turn out to be steroid hormones in the fullest sense: they coordinate not only how a plant builds itself but how it fuels the construction. The new study distills that coordination to its essence—a kinase, an enzyme, and a single phosphorylation mark that stands between a seed’s stored fat and the sugar that wakes it into growth. For researchers, the result redraws a boundary that plant biology has often taken for granted, dissolving the line between signaling and metabolism, two disciplines long treated as separate provinces. For everyone else, it is a reminder that the grand dramas of the living world—a seedling breaking through the soil, a crop standing tall through drought—frequently turn on events far too small to see: one phosphate group added, or held back, at precisely the moment a hormone says go. The study is published in Nature Plants.
Subject of Research: Regulation of sugar synthesis in plants by the brassinosteroid signaling pathway, specifically how inhibition of BIN2 kinase–mediated phosphorylation of the gluconeogenic enzyme phosphoenolpyruvate carboxykinase (PEPCK) promotes sugar production.
Subject of Research: Biology
Article Title: Brassinosteroids promote sugar synthesis by inhibiting BIN2 phosphorylation of phosphoenolpyruvate carboxykinase
Article References: Zhang, H., Aizezi, Y., Bessho-Uehara, K., Chaudhary, A., Trinh, C. S., Xu, S.-L., & Wang, Z.-Y. (2026). Brassinosteroids promote sugar synthesis by inhibiting BIN2 phosphorylation of phosphoenolpyruvate carboxykinase. Nature Plants. https://doi.org/10.1038/s41477-026-02379-5
Image Credits: AI Generated
DOI: 10.1038/s41477-026-02379-5
Keywords: Brassinosteroids, BIN2 kinase, phosphoenolpyruvate carboxykinase, sugar synthesis, gluconeogenesis, plant hormone signaling, protein phosphorylation, GSK3-like kinase, carbon metabolism, seedling establishment, crop improvement
Cite Scienmag News
APA MLA Chicago
Lydia K. (August 29, 2026). Brassinosteroids boost sugar synthesis by blocking BIN2 phosphorylation of PEP carboxykinase. Scienmag. https://scienmag.com/brassinosteroids-boost-sugar-synthesis-by-blocking-bin2-phosphorylation-of-pep-carboxykinase/
Lydia K. “Brassinosteroids boost sugar synthesis by blocking BIN2 phosphorylation of PEP carboxykinase.” Scienmag, 29 August 2026, https://scienmag.com/brassinosteroids-boost-sugar-synthesis-by-blocking-bin2-phosphorylation-of-pep-carboxykinase/. Accessed 29 August 2026.
Lydia K. “Brassinosteroids boost sugar synthesis by blocking BIN2 phosphorylation of PEP carboxykinase.” Scienmag. August 29, 2026. https://scienmag.com/brassinosteroids-boost-sugar-synthesis-by-blocking-bin2-phosphorylation-of-pep-carboxykinase/
Copy citation Download RIS
Tags: BIN2 kinase regulation in plantsBIN2 kinase role in plant biochemistrybiochemistry of seed germination and energy conversionbrassinosteroids and plant growthbrassinosteroids and sugar metabolismbrassinosteroids influence on seedling energy supplybrassinosteroids signaling pathway in plant metabolismenzyme protection mechanism by plant hormonesevolutionary parallels between plant and animal sugar regulationevolutionary parallels between plant and human sugar regulationhormonal control of plant carbohydrate synthesisimpact of brassinosteroids on seed germination and earlymolecular mechanisms of plant sugar productionPEP carboxykinase enzyme controlPEP carboxykinase regulationphosphorylation blocking of metabolic enzymes in plantsplant growth promotion and sugar synthesisplant growth regulation and sugar productionplant hormone signalingplant signaling pathways affecting energy storageplant steroid hormonesplant steroid hormones and metabolic enzyme protectionsugar metabolism regulation in plants
